Bipolar-II-Störungen

Die bipolare affektive Störung (kurz: bipolare Störung) beschreibt eine Gruppe von affektiven Störungen, die durch depressive sowie manische/hypomane Episoden gekennzeichnet sind. Der Artikel befasst sich mit den diagnostischen und therapeutischen Herausforderungen der Bipolar-II-Störung.

Abstract

Bipolar affective disorder (short: bipolar disorder) describe a group of affective disorders characterised by depressive as well as manic/hypomanic episodes. The article deals with the diagnostic and therapeutic challenges of bipolar II disorder.

Schlüsselwörter

Bipolar-II-Störungen - Depression - Hypomanie - Phasenprophylaxe - Pharmakotherapie

Key words

Bipolar-II disorders - depression - hypomania - phase prophylaxis - pharmacotherapy

Publikationsverlauf

Artikel online veröffentlicht:
20. April 2022

• Literatur

• 1 Leonhard K. Classification of endogenous Psychoses and their differential Etiology. New York: Springer; 1999
• 2 American Psychiatric Association. DSM-5 Diagnostic and statistical Manual of mental Disorders 2013; DOI: 10.1177/0963662519868969.
• 3 Laux G, Möller H. Einteilung/Klassifikation. In: Laux G, Möller H, Hrsg. Memorix Psychiatrie und Psychotherapie. 2. akt. Aufl Stuttgart: Thieme; 2011. DOI: 10.1055/b-00000016
• 4 World Health Organization. The ICD-10 Classification of mental and behavioural Disorders: diagnostic Criteria for Research. Geneva: World Health Organization; 1993. DOI: 10.1111/add.14482
• 5 Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psy 2003; 64: 161-174
• 6 Baldessarini RJ, Vazquez GH, Tondo L. Bipolar depression: a major unsolved challenge. Int J Bipolar Dis 2020; 8: 1 DOI: 10.1186/s40345-019-0160-1.
• 7 Maj M, Pirozzi R, Formicola AM. et al. Reliability and validity of four alternative definitions of rapid-cycling bipolar disorder. Am J Psy 1999; 156: 1421-1424 DOI: 10.1176/ajp.156.9.1421.
• 8 Judd LL, Akiskal HS, Schettler PJ. et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psy 2003; 60: 261-269 DOI: 10.1001/archpsyc.60.3.261.
• 9 Akiskal HS, Maser JD, Zeller PJ. et al. Switching from ‘unipolar’ to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psy 1995; 52: 114-123
• 10 Marneros A. Handbuch der unipolaren Erkrankungen. Stuttgart: Thieme; 1999
• 11 Coryell W, Andreasen NC, Endicott J. et al. The significance of past mania or hypomania in the course and outcome of major depression. Am J Psy 1987; 144: 309-315 DOI: 10.1176/ajp.144.3.309.
• 12 Fogarty F, Russell JM, Newman SC. et al. Epidemiology of psychiatric disorders in Edmonton. Mania Acta Psy Scand 1994; 376: 16-23
• 13 Suppes T, Leverich GS, Keck PE. et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Dis 2001; 67: 45-59 DOI: 10.1016/s0165-0327(01)00432-3.
• 14 Berk M, Seetal D. Bipolar II disorder: a review. Bipolar Dis 2005; 7: 11-21 DOI: 10.1111/j.1399-5618.2004.00152.x.
• 15 Seemüller F, Riedel M, Dargel S. et al. Bipolare Depression. Spektrum klinischer Erscheinungsbilder und Abgrenzbarkeit von der unipolaren Depression. Nervenarzt 2010; 81: 531-538
• 16 Rowland T, Marwaha S. Epidemiology and risk factors for bipolar disorder. Ther Adv Psychopharmacol 2018; 8: 251-269 DOI: 10.1177/2045125318769235.
• 17 Leboyer M, Henry C, Paillere-Martinot ML. et al. Age at onset in bipolar affective disorders: a review. Bipolar Dis 2005; 7: 111-118 DOI: 10.1111/j.1399-5618.2005.00181.x.
• 18 Cassidy F, Carroll BJ. Vascular risk factors in late onset mania. Psychol Med 2002; 32: 359-362 DOI: 10.1017/s0033291701004718.
• 19 DGPPN. S3-Leitlinie zur Diagnostik und Therapie Bipolarer Störungen. Mai 2020. AWMF-Register Nr. 038-019.
• 20 Stahl EA, Breen G, Forstner AJ. et al. Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder. Nat Genet 2019; 51: 793-803 DOI: 10.1038/s41588-019-0397-8.
• 21 Vinberg M, Mikkelsen RL, Kirkegaard T. et al. Differences in clinical presentation between bipolar I and II disorders in the early stages of bipolar disorder: A naturalistic study. J Affect Disord 2017; 208: 521-527 DOI: 10.1016/j.jad.2016.10.031.
• 22 Judd LL, Akiskal HS, Schettler PJ. et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psy 2003; 60: 261-269 DOI: 10.1001/archpsyc.60.3.261.
• 23 Losekam S, Konrad C, Steinert C. et al. Praxis der Psychotherapie der unipolaren Depression. Therapie der Depression. Heidelberg: Springer; 2017
• 24 Goodwin FK, Jamison KR. Manic-depressive illness. Bipolar disorders and recurrent depression. 2. New York: Oxford University; 2002
• 25 Ayuso-Gutierrez JL, Ramos-Brieva JA. The course of manicdepressive illness. A comparative study of bipolar I and bipolar II patients. J Affect Dis 1982; 4: 9-14 DOI: 10.1016/0165-0327(82)90013-1.
• 26 Phillips ML, Kupfer DJ. Bipolar disorder diagnosis: challenges and future directions. Lancet 2013; 381: 1663-1671 DOI: 10.1016/S0140-6736(13)60989-7.
• 27 Altshuler L, Post RM, Mikalauskas K. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psy 1995; 152: 1130-1138
• 28 Dilsaver SC, Swann AC. Mixed mania: apparent induction by a tricyclic antidepressant in five consecutively treated patients with bipolar depression. Biol Psychiatry 1995; 37: 60-62 DOI: 10.1016/0006-3223(94)00194-8.
• 29 Suppes T, Hirschfeld RM, Vieta E. et al. Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies. World J Biol Psy 2008; 9: 198-211
• 30 Weisler RH, Calabrese JR, Thase ME. et al. Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies. J Clin Psy 2008; 69: 769-782
• 31 Swartz HA, Thase ME. Pharmacotherapy for the treatment of acute bipolar II depression: current evidence. J Clin Psy 2011; 72: 356-366 DOI: 10.4088/JCP.09r05192gre.
• 32 Sidor MM, Macqueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psy 2011; 72: 156-167 DOI: 10.4088/JCP.09r05385gre.
• 33 Gijsman HJ, Geddes JR, Rendell JM. et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psy 2004; 161: 1537-1547 DOI: 10.1176/appi.ajp.161.9.1537.
• 34 Altshuler L, Suppes T, Black D. et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at I-year follow-up. Am J Psy 2003; 160: 1252-1262
• 35 Bond D, Noronha M, Kauer-Sant’Anna M. et al. Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. J Clin Psy 2008; 10: 1589-1601 DOI: 10.4088/jcp.v69n1009.